openPR Logo
Press release

China to be the Second Largest IVD Market by 2017

02-27-2013 04:34 PM CET | Health & Medicine

Press release from: RNCOS E-Services Pvt. Ltd.

/ PR Agency: RNCOS E-Services Pvt. Ltd.
Increased healthcare spending with emphasis on expansion and up-gradation of healthcare facilities will boost the IVD market in em

Increased healthcare spending with emphasis on expansion and up-gradation of healthcare facilities will boost the IVD market in em

According to a new report by RNCOS, “In-Vitro Diagnostics Market Analysis to 2017”, in 2012, the US led the global IVD market with around 41% share. It was followed by Japan and Germany, which stood at the second and the third position, respectively. The emerging markets of China, India, Mexico and Brazil are however, growing much faster than the developed ones. They are likely to experience a double-digit growth rate in the coming years. Moreover, China is slated to overtake Japan as the second biggest IVD market by 2017.

Our study reveals that the government in emerging economy of China is spending heavily on the construction and up-gradation of its healthcare infrastructure. The report studies the changes that are expected to be spurred due to these developments, highlighting the areas that will provide maximum opportunities for investment and growth.

Like China, other key IVD markets have also been analyzed in detail which will give the reader a detailed understanding of the market dynamics in the region. Each region’s current and future outlook to 2017 has been discussed. Further, each market has been broken down into eight distinct clinical segmentations and their current and future outlook to 2017 has been analyzed to provide a thorough opportunity assessment.

Besides, the report has delved into the business dynamics of the major players of the market. To provide a thorough understanding of the company’s business model, company’s current and historical financials have been analyzed. Moreover, each company’s strengths and weaknesses along with their recent industrial activities have also been assessed. This will help the reader to gain a deeper insight into the current competitive landscape and position its company accordingly.

The report provides a thorough research and rational analysis of the current status and expected position of the global IVD market. The analysis of the emerging sectors and key players in the market provides a holistic view to the reader. Explaining some of the constraints faced by the industry, the study also covers the emerging trends which would have a positive impact on the market growth. Overall, the report contains key actionable insights that will help the reader to gain a deeper knowledge of the industry, identify key opportunities and design suitable business strategies.

For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM472.htm

Some of our Related Reports are:

- US Telelaparoscopy Opportunity Analysis (http://www.rncos.com/Report/IM469.htm)
- US Proton Therapy Market Analysis to 2017 (http://www.rncos.com/Report/IM465.htm)
- US Personalized Cancer Genome Sequencing Market (http://www.rncos.com/Report/IM453.htm)
- Brazil Healthcare - New Opportunities for Growth (http://www.rncos.com/Report/IM451.htm)
- US Non-Invasive Prenatal Diagnostics - Market Insight (http://www.rncos.com/Report/IM450.htm)

Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm

About RNCOS

RNCOS specializes in Industry intelligence and creative solutions for contemporary business segments. Our professionals analyze the industry and its various components, with a comprehensive study of the changing market behavior. Our accuracy and data precision proves beneficial in terms of pricing and time management that assist the intending consultants in meeting their objectives in a cost-effective and timely manner.

None

B-129, Sector 6 Noida - 201301
91-120-4224-700
91-120-4224-707

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release China to be the Second Largest IVD Market by 2017 here

News-ID: 253453 • Views: 4189

More Releases from RNCOS E-Services Pvt. Ltd.

Malaysia Convenience Store Witnessing Tremendous Growth
“Rapid expansion plans of major convenience stores in Malaysia such as 7-Eleve and 99 Speed Mart are expected to drive the market.” says RNCOS Malaysia Convenience store has been witnessing a tremendous growth in the retail industry. Key players in the country are widening their foot prints in retail industry by innovatively increasing the product portfolio as per the consumer behavior and increasing the number of stores. There is a cut
Growing Opportunity in the Global Enterprise Software Market
“Increasing adoption of enterprise resource management software, customer relationship management software and human resource management software is expected to drive the Global Enterprise Software market.” Says RNCOS The global enterprise software market has reported a significant growth in the recent years and is presenting ample opportunities to the industry’s players. With increasing global competition and rising awareness regarding enterprises software across the globe, the worldwide enterprise software market is poised to
Global Wearable Medical Device Market Outlook 2020
By wearable medical devices we understand non-invasive, autonomous health tools, which aid in clinical monitoring beyond the hospitals. The application of wearable ranges from monitoring glucose levels in blood to managing chronic diseases such as heart diseases, asthma and diabetes. These devices generally provide non-invasive sensing, local processing, user feedback, and communication capabilities. In the latest report “Global Wearable Medical Device Market Outlook 2020”, RNCOS’ analysts have endeavored to
Global Point-of-Care Diagnostics Market Outlook 2020
It is widely accepted that disease prevention and risk-reduction strategies have the potential to lower disease burden as well as improve the overall health of individuals. POCT technology offers such potential for diagnosis and treatment of patients, as it facilitates rapid availability of test results and hence, early clinical decision making and intervention. Amidst a rising disease incidence, reduced budget, growing focus towards personalization of care, and ever-increasing integration of

All 5 Releases


More Releases for IVD

Asia IVD Market
According to a new report published by Allied Market Research, the Asia Pacific In-vitro diagnostics market was valued at $12.9 billion in 2015, and is expected to reach $19.0 billion registering a CAGR of 5.6% during 2016 to 2022. The report offers a detailed analysis of the key segments, top investment pockets, changing dynamics, market size & estimations, and competitive scenario. Download Free Sample Report @ https://www.alliedmarketresearch.com/request-sample/1256 The Asia-Pacific IVD market is
LAMEA IVD Market | Business Development Strategies
LAMEA IVD market size was valued at $7,413 million in 2016, and is projected to reach at $10,316 million by 2023, growing at a CAGR of 4.7% from 2017 to 2023. The immunodiagnostics segment accounted for more than two-ninths share of the total market in 2016. Request Sample Report at: https://www.alliedmarketresearch.com/request-sample/4137 In vitro diagnostics (IVD) are medical devices and reagents used for examination of the body samples such as blood, tissue, and
Global IVD Products Market Research Report
This report studies the global IVD Products market status and forecast, categorizes the global IVD Products market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report Abbott Laboratories Danaher Corporation Johnson and Johnson Roche Diagnostics Siemens Healthcare BD Biomerieux Bio-Rad Laboratories Ortho Clinical
Europe IVD Market to Witness $19,124 Million Value by 2023
According to a new report published by Allied Market Research, titled, Europe IVD Market by Product Type, Techniques, Application, and End Users: Global Opportunity Analysis and Industry Forecast, 2017-2023, Europe IVD market was valued at $19,124 million in 2016, and is projected to reach at $26,623 million by 2023, growing at a CAGR of 4.7% from 2017 to 2023. In vitro diagnostic tests are performed using biological samples to detect the
Global IVD Reagents Market Applications & Strategies, 2022
Qyresearchreports include new market research report "Global IVD Reagents Market Research Report 2017" to its huge collection of research reports. The market study on the global IVD Reagents market is a professional tool that scrutinizes vital market indicators to understand the progression of the said between 2017-2022. The research report on the global IVD Reagents market studies historical and current performance, which are used to provide projections for crucial market indices.
IVD Market– Projections & Estimations, 2017–2023
Big Market Research added a report on “IVD Market By Product Type (Reagents, Instruments And Software & Services), By Technique (Immunodiagnostics, Blood Testing, Molecular Diagnostics, Tissue Diagnostics, Clinical Chemistry, And Other IVD Techniques), By Application (Infectious Diseases, Cancer, Cardiac Diseases, Immune System Disorders, Nephrological Diseases, Gastrointestinal Diseases, And Other Indications), And By End Users (Standalone Laboratory, Hospitals, Academic And Medical Schools, Point Of Care Testing, And Others) - Global Opportunity